Biovail Settles For $10 Million On SEC Fraud Charges
This article was originally published in The Pink Sheet Daily
Executive Summary
Four executives still accused of overstating earnings to deceive investors.
You may also be interested in...
Phase III Efficacy Still Unproven, Pimavanserin Bags Acadia Deal With Biovail
First of two Phase III studies in Parkinson’s disease psychosis is set to yield data in the third quarter.
Phase III Efficacy Still Unproven, Pimavanserin Bags Acadia Deal With Biovail
First of two Phase III studies in Parkinson’s disease psychosis is set to yield data in the third quarter.
Biovail Agrees To Cardizem LA Guilty Plea
Federal charges say 2003 program gave docs $1,000 to write scrips.